Company Overview and News

 
The Zacks Analyst Blog Highlights: UnitedHealth, Netflix, Caterpillar, M&T Bank and Infosys

11h zacks
Chicago, IL – April 19, 2018 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include UnitedHealth (UNH - Free Report) , Netflix (NFLX - Free Report) , Caterpillar (CAT - Free Report) , M&T Bank (MTB - Free Report) and Infosys (INFY - Free Report) .
Upvote Downvote

 
U.S. stock futures search for a catalyst as earnings stay in focus - MarketWatch

16h marketwatch
U.S. stock-index futures pointed to a roughly flat open Thursday, putting the main gauges on track for a second-straight day of muted action.
Upvote Downvote

 
Weekly Edge: Earnings Season Is Upon Us

19h seekingalpha
Companies in the United States - among them, Netflix (NASDAQ:NFLX), Goldman Sachs (NYSE:GS), and UnitedHealth Group (NYSE:UNH) -have begun reporting their earnings for the first quarter of 2018, and the results have been strong so far. According to MarketWatch, earnings growth is expected to be 17.3% for S&P components, which is the fastest rate of expansion since 2011. The Wall Street Journal noted that 74% of the 43 companies that have reported earnings beat expectations.
Upvote Downvote

 
Top Stock Reports for UnitedHealth, Netflix & Caterpillar

2018-04-18 zacks
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including UnitedHealth (UNH), Netflix (NFLX) and Caterpillar (CAT). These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.
Upvote Downvote

 
Closed-End Fund THQ: Large-Cap Healthcare Stocks At An 8% Yield

2018-04-18 seekingalpha
THQ holds solid large-cap healthcare stocks that have been underperforming due to uncertainty surrounding the healthcare industry.
Upvote Downvote

 
Healthy Q1 Earnings at UnitedHealth: ETFs to Watch

2018-04-18 zacks
The largest U.S. health insurer UnitedHealth Group (UNH - Free Report) reported robust first-quarter 2018 results. The company breezed past the Zacks Consensus Estimate on both the top and the bottom lines as well as raised its full-year outlook, sending its shares rallying. UNH gained 3.6% on Apr 17, after reporting earnings.
Upvote Downvote

 
Static UnitedHealth Group Inc Stock Doesn’t Offer Much Upside | InvestorPlace

2018-04-18 investorplace
Thanks to the dramatic differences in approach between the current and prior presidential administrations, healthcare is an incredibly unpredictable sector. Nevertheless, if you’re UnitedHealth Group Inc (NYSE:UNH), you’ve got a tight handle on things. As one of the world’s biggest healthcare companies, UNH stock seems like a sure bet.
Upvote Downvote

 
Stock Market News For Apr 18, 2018

2018-04-18 zacks
U.S. stock markets continued their winning streak for the second consecutive day supported by robust first-quarter earnings results and strong economic data. All three major indexes closed at highest level in about a month. Moreover, all three indexes closed above their 50-day moving average, an important metric to calculate short-term price momentum of securities.
Upvote Downvote

 
Expect Stocks to Continue Forward Momentum

2018-04-18 investorplace
Stocks enjoyed another buying surge on Tuesday, with investors turning away from geopolitical concerns to concentrate on the flow of Q1 earnings results. And they’ve been good. Helping push the major averages over their 50-day moving averages, something that hasn’t happened since March 21 or earlier.
Upvote Downvote

 
Tech rally boosts US stocks, Netflix surges

2018-04-17 channelnewsasia
NEW YORK: Wall Street stocks powered higher on Tuesday (Apr 17) on strong corporate earnings, with a blowout report from Netflix igniting a rally in technology shares.
Upvote Downvote

 
Netflix leads Wall Street higher, recovering this year's losses

2018-04-17 nbr.co.nz
Stocks on Wall Street continue to respond to strong corporate results, sending the Dow industrials back into positive territory for 2018.
Upvote Downvote

 
GE, UnitedHealth Carry the Dow Higher Tuesday

2018-04-17 247wallst
April 17, 2018: Markets opened higher for a fourth straight session Tuesday on a solid first-quarter earnings gains among some blue chip stocks. Housing starts came in higher, but gains are flattening out and productivity gains remain muted by excess capacity. Some analysts are looking at earnings increases more as a result of lower tax rates than a fundamental improvement.
Upvote Downvote

 
IBM Stock Price - International Business Machines Corp. Stock Quote (U.S.: NYSE) - MarketWatch

2018-04-17 marketwatch
International Business Machines Corp. rode the success of old technology to big gains at the end of last year, but investors will be looking for success from newer businesses in order to believe in Big Blue’s future.
Upvote Downvote

 
UnitedHealth Group's (UNH) CEO Andrew Hayek on Q1 2018 Results - Earnings Call Transcript

2018-04-17 seekingalpha
Good morning. I will be your conference operator today. Welcome to the UnitedHealth Group First Quarter 2018 Earnings Conference Call. [Operator Instructions]. As a reminder, this call is being recorded.
Upvote Downvote

 
UnitedHealth Group Inc Stock: Wall Street’s Biggest Moat

2018-04-17 investorplace
UnitedHealth Group Inc (NYSE:UNH), the giant health insurer, beat the street on April 17 and raised estimates, illustrating its dominance in the healthcare space.
Upvote Downvote

Related Articles

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...

VSTM: Verastem Analysis and Research Report

2018-04-12 - Asif

Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...

CUSIP: 91324P102